A glucose-lowering drug can protect kidneys in type 1 diabetes patients
Dapagliflozin, can protect the kidneys in patients with type 1 diabetes. According to results shown in a new study published in the Lancet.
Close to 17 percent of patients recovered from COVID-19 could still carry virus
Although meeting the criteria for discontinuation of quarantine, patients with persistent respiratory symptoms are more likely to test positive for the virus, finds a new study in the…
Gut symptoms and low mood may be linked to a later diagnosis of inflammatory bowel disease
A new study, published in Gut, has found depression is more common among people with Crohn’s disease or ulcerative colitis in the years before they are diagnosed with…
Higher average life expectancy after obesity surgery
People who have undergone bariatric surgery live three years longer, on average, than those given conventional treatment for their obesity, a University of Gothenburg study shows. Compared with…
Mammography screening saves lives also in older age
Mammography is efficient also for women over the age of 70. For women invited to regular mammography screening over the age of 70, the reduction in mortality rate…